Today's Alert

PSID (PositiveID Corp) is The Wolf’s New SUB-PENNY Alert!

Posted on by in Today’s Alert

PSID (PositiveID Corp) is my New Alert!
Last Price: .0023  |  SEC Filings  |  Latest News

Begin your research at

Today we head back into the wild and volatile world of Ultra-Low Priced Sub-Pennies with a company who’s potentially undervalued price will ASTOUND you!

And that’s because of all the BIG things this company is doing in the growing $140 BIL Medical Device & Diagnostics Market!

We’re talking about a company who has worked with both Boeing AND Homeland Security and has seen ENORMOUS Revenue Growth year-over-year….yet still trades at SUB-PENNY PRICES!

Insane right?!?  So let’s get right to it…


PositiveID Corporation (PSID) is a life sciences tools and diagnostics company that develops biological detection and diagnostics systems and specializes in the development of microfluidic systems for the automated preparation of and performance of biological assays.

PSID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and Homeland Security.

Sounds like a mouthful right?

Well, PSID’s customers get it!  In the last year, the company saw an 89% INCREASE in Revenues!  That’s also a 488% INCREASE since 2014!

And the company appears to be very optimistic of the future as well…

PositiveID Projects Revenue Growth of More Than 30% Year-over-Year through First Quarter of 2018

And did I mention PSID’s insanely LOW FLOAT of just 7.3 MIL Shares a/o June14?  If still accurate, that’s just a mere $14,700. at the current price!

And yet, how is it that PSID still trades at SUB-PENNY prices!?!  Well, let’s dig in…


M-BAND:  PositiveID is focused primarily on its M-BAND airborne biot-threat detector, which was developed under contract with the U.S. Department of Homeland Security (“DHS”) Science & Technology directorate.

The M-BAND detection system continuously and autonomously analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. Results from individual M-BAND instruments are reported via a secure wireless network in real time to give an accurate and up-to-date status of field conditions.

M-BAND performs high specificity detection for up to six organisms on the Centers for Disease Control’s category A and B select agents list.

Firefly Dx System: Designed to deliver molecular diagnostic results from a sample in less than 30 minutes at the point-of-need, using a portable, handheld system.

The goal of the Company’s Firefly Dx is to enable accurate diagnostics leading to more rapid and effective treatment than what is currently available with existing systems.

Firefly is being developed further for a broad range of biological detection situations for applications including military, agricultural and healthcare. The system has already demonstrated the ability to detect and identify other common pathogens and diseases such as various strains of influenza, E. coli, methicillin-resistant staphylococcus aureus (“MRSA”) and human papilloma virus (“HPV”).

E-N-G Mobile Labs:  PositiveID’s wholly owned subsidiary provides specialty vehicle manufacturing for TV news vans and trucks, emergency response trailers, mobile command centers, mobile labs, and other special purpose vehicles.

Major applications include mobile TV broadcasting, microwave and satellite uplink trucks, emergency response vehicles, communications command and control, surveillance vans, medical, dental, and health laboratories and clinics, and many other applications.

But that’s not all…

PositiveID Commences Production of Next Generation Caregiver Thermometer with Bluetooth

The thing I’m most excited for with PSID is last week’s HUGE NEWS regarding the launch of it’s newest DISRUPTIVE product – Caregiver® See below…

See it in action HERE

DELRAY BEACH, Fla., Dec. 06, 2017 –PositiveID Corporation (PSID), a life sciences company focused on detection and diagnostics, is excited to announce that its Thermomedics subsidiary has commenced production of its disruptive, next generation Caregiver® thermometer with Bluetooth® capability. Caregiver with Bluetooth will be commercially available in January 2018.

(that’s less than a month away!!!)

The new device can connect wirelessly to electronic health records systems and patient monitoring stations in hospitals to transmit temperature readings automatically into a patient’s record. According to recent research by MarketsandMarkets, the Bluetooth Smart and Smart Ready market is expected to be worth $5.34 BIL by 2023. Product teams able to elevate next generation devices to take advantage of this trend often experience a corresponding increase in market adoption.

“Incorporating wireless communication of temperature readings is a logical next step for our Caregiver product,” says Gary O’Hara, Chief Technology Officer of Thermomedics.

“By offering hospitals and clinics the ability to connect and transmit data seamlessly to patient monitoring stations, we eliminate extra steps for healthcare professionals, enabling them to spend more time on patient care, decreasing the likelihood of errors.”

PositiveID’s FDA-cleared Caregiver is a professional-grade, infrared thermometer capable of delivering an oral-equivalent temperature directly from the forehead in one to two seconds.

The lack of skin contact and absence of probe cover supplies eliminate two chief concerns of healthcare facilities related to thermometry: the risk of cross-contamination of highly-infectious diseases such as Ebola, and unnecessary costs related to probe covers – as much as $0.10 per temperature, or an estimated $250 per year per device.

PositiveID executives believe its next generation Bluetooth-enabled model holds the potential to boost adoption of the Caregiver line to take advantage of the growing use of infrared thermometry, which is the fastest growing segment of the $1 BIL global temperature monitoring device market.

With tremendous Revenue Growth and projections for next year  +  the upcoming Launch of it’s Caregiver product in LESS THAN A MONTH – could now be the single most perfect time EVER to check out PSID while it’s trading at bottom barrel SUB-PENNY Prices?

Needless to say, PSID at these prices is a true enigma!  But it may not be for long so…

Make sure you put it on your screen RIGHT NOW and Follow on Twitter for Updates + Play-by-Play!


Please read our Full Disclaimer:

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The paying party may own shares and may liquidate them during the promotional period.

PLEASE NOTE WELL: and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice.


You are reading this newsletter because you have subscribed via our Opt-In Signup form on our Website. If you have been subscribed by mistake, you may unsubscribe HERE.

This Newsletter is now owned and operated by Link Media. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Link Media and/or it’s subscriber base. Our website and newsletter are for Entertainment purposes only. This newsletter is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. Full disclaimer can be read at

We encourage all to read the SEC INVESTOR ALERT before reading our Newsletter.

Release of Liability: Through use of this email and/or website advertisement viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by or an offer or solicitation to buy or sell any security.

COMPENSATION: has been compensated twenty thousand dollars cash via bank wire by a third party, Awareness Consulting Network LLC for a one day PositiveID Corp. advertising services contract. does not own any shares of PSID. does not investigate the background of any third party. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. may purchase shares on the open market of any mentioned company following the dissemination of this email. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news & press releases, changes in corporate structure, or changes in share structure.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. is compliant with the Can Spam Act of 2003. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage.

In preparing this publication, has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. is not responsible for any claims made by the companies advertised herein, nor is responsible for any other promotional firm, its program or its structure.